SMARCB1 and neoplasm: The direct connection between SNF5 and MYC explains the recurring activation of MYC target gene signatures in MRT8–10 and, because of the broad suite of oncogenic activities possessed by MYC22, can help rationalize how loss of a single tumor suppressor can have such profound effects on cellular pathophysiology.